# HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

> **NCT00530777** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 148 (actual)

## Conditions studied

- HIV Infections
- Herpes Simplex

## Interventions

- **DRUG:** valacyclovir
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00530777
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530777, "HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00530777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*